The stock of Natera Inc (NASDAQ:NTRA) is a huge mover today! The stock increased 4.32% or $0.46 during the last trading session, hitting $11.11. About 194,688 shares traded hands. Natera Inc (NASDAQ:NTRA) has risen 41.62% since February 26, 2016 and is uptrending. It has outperformed by 31.20% the S&P500.
The move comes after 6 months positive chart setup for the $587.99 million company. It was reported on Oct, 1 by Barchart.com. We have $13.78 PT which if reached, will make NASDAQ:NTRA worth $141.12 million more.
Analysts await Natera Inc (NASDAQ:NTRA) to report earnings on November, 10. They expect $-0.52 earnings per share, down 33.33% or $0.13 from last year’s $-0.39 per share. After $-0.46 actual earnings per share reported by Natera Inc for the previous quarter, Wall Street now forecasts 13.04% negative EPS growth.
Natera Inc (NASDAQ:NTRA) Ratings Coverage
Out of 5 analysts covering Natera Inc (NASDAQ:NTRA), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Natera Inc has been the topic of 13 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating given on Tuesday, August 4 by Robert W. Baird. The stock has “Buy” rating given by Benchmark on Monday, May 23. The firm earned “Neutral” rating on Monday, July 27 by Wedbush. As per Monday, July 27, the company rating was initiated by Cowen & Co. The firm has “Buy” rating given on Tuesday, April 19 by Benchmark. Wedbush upgraded the shares of NTRA in a report on Monday, September 28 to “Outperform” rating. The firm has “Buy” rating given on Wednesday, May 11 by Benchmark. Morgan Stanley initiated it with “Equal Weight” rating and $20 target price in Monday, July 27 report. Wedbush maintained the stock with “Neutral” rating in Friday, August 28 report. The stock has “Overweight” rating given by Morgan Stanley on Friday, August 14.
According to Zacks Investment Research, “Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.”
More notable recent Natera Inc (NASDAQ:NTRA) news were published by: Quotes.Wsj.com which released: “News Natera Inc.NTRA” on June 30, 2015, also Prnewswire.com with their article: “Natera Announces the Appointment of Kimberly Martin, MD as Senior Global …” published on April 25, 2016, Fool.com published: “Natera, Inc. Surged 20% Higher in December. Here’s Why.” on January 08, 2016. More interesting news about Natera Inc (NASDAQ:NTRA) were released by: Prnewswire.com and their article: “Natera Reports First Quarter 2016 Financial Results” published on May 10, 2016 as well as Prnewswire.com‘s news article titled: “Natera to Present at the Baird 2016 Global Healthcare Conference” with publication date: September 02, 2016.
NTRA Company Profile
Natera, Inc., incorporated on January 26, 2007, is a diagnostics company. The Firm operates a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) providing a host of preconception and prenatal genetic testing services. The Firm has a subsidiary that operates in the state of Texas.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.